Cargando…
Clinical and economic considerations of antiobesity treatment: a review of orlistat
The objective of this study was to review the current knowledge about the use of orlistat from clinical and economic perspectives, and to assess this drug’s public health impact. Weight reduction by current antiobesity drugs, compared to placebo, is at most around 5 kg. Orlistat, the most studied an...
Autor principal: | Zohrabian, Armineh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169961/ https://www.ncbi.nlm.nih.gov/pubmed/21935315 |
Ejemplares similares
-
External Costs of Risky Health Behaviors Associated with Leading Actual Causes of Death in the U.S.: A Review of the Evidence and Implications for Future Research
por: Zohrabian, Armineh, et al.
Publicado: (2010) -
Obesity management: Update on orlistat
por: Drew, Belinda S, et al.
Publicado: (2007) -
Cost-effectiveness of West Nile Virus Vaccination
por: Zohrabian, Armineh, et al.
Publicado: (2006) -
Orlistat in the prevention of diabetes in the obese patient
por: Mancini, Marcio C, et al.
Publicado: (2008) -
West Nile Virus Economic Impact, Louisiana, 2002
por: Zohrabian, Armineh, et al.
Publicado: (2004)